QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=4DA2ED7BBCCA5CAD0216612FD8B5B135;jsessionid=402CD09D12027F9CEE86DE7EF9FFC046;jsessionid=F207DE96A5CEB97D510F0FCCB44213E9;jsessionid=0595184E88163C185B3B9D82B9FDA3EE;jsessionid=124C6B28B6FE75C141A217BCD13AB699;jsessionid=EC7930FA12FA7E32DD98FC7A5161EC9E (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
4. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.
5. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=4DA2ED7BBCCA5CAD0216612FD8B5B135;jsessionid=402CD09D12027F9CEE86DE7EF9FFC046;jsessionid=F207DE96A5CEB97D510F0FCCB44213E9;jsessionid=0595184E88163C185B3B9D82B9FDA3EE;jsessionid=124C6B28B6FE75C141A217BCD13AB699;jsessionid=EC7930FA12FA7E32DD98FC7A5161EC9E